Trial Profile
Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer metastases; Osteoporosis
- Focus Biomarker; Pharmacodynamics
- 03 Nov 2010 Status changed from recruiting to discontinued according to ClinicalTrials.gov.
- 06 Sep 2009 New trial record